国际麻醉学与复苏杂志   2020, Issue (11): 0-0
    
右美托咪定通过PI3K/Akt通路减弱大鼠离体心脏缺血/再灌注损伤中LC3表达
刘琨, 罗兴晶1()
1.复旦大学附属儿科医院
Dexmedetomidine decreases the expression of LC3 in isolated rat heart during ischemia‑reperfusion injury through the PI3K/Akt pathway
 全文:
摘要:

目的 观察右美托咪定(dexmedetomidine, Dex)对大鼠离体心脏缺血/再灌注损伤中微管相关蛋白1轻链3(microtubule‑associated protein 1 light 3, LC3)及磷脂酰肌醇3‑激酶/蛋白激酶B(phosphatidy‑linositol 3‑kinase/protein kinase B, PI3K/Akt)信号通路的影响,探讨Dex对心肌的保护作用。 方法 健康成年雄性SD大鼠48只,8~10周龄,体重250~300 g,采用Langendorff灌注装置制备离体心脏缺血/再灌注模型。取模型制备成功的心脏48个,采用随机数字表法将其分为4组(n=12):空白对照组(NC组),K‑H液持续灌注120 min;缺血/再灌注组(I/R组),K‑H液灌注30 min,全心缺血30 min,再灌注60 min;Dex预处理组(Dex+I/R组),K‑H液灌注10 min后再用含有 25 μg/L Dex的K‑H液灌注15 min,K‑H液洗脱5 min,全心缺血30 min,再灌注60 min;Dex预处理+渥曼青霉素组(Dex+I/R+W组),开胸前30 min大鼠腹腔注射渥曼青霉素15 μg/kg,其余处理同Dex+I/R组。于平衡末(K‑H液灌注30 min时)及再灌注末记录心率、左心室内压力上升/下降速率最大值(the maximum rate of increase or decrease of left ventricular pressure, ±dp/dtmax)、左心室发展压(left ventricular development pressure, LVDP)、左心室舒张末期压(left ventricular diastolic pressure, LVEDP)。于再灌注末收集冠状动脉流出液积,酶标仪法检测乳酸脱氢酶(lactate dehydrogenase, LDH)活性;取心肌组织,2,3,5‑氯化三苯基四氮唑(2,3,5‑triphenyltetrazoliumchlofide, TTC)染色法检测心肌梗死面积,计算心肌梗死面积百分比;采用Western blot法检测自噬标记物LC3以及Akt、磷酸化蛋白激酶B(phosphorylated Akt, p‑Akt)、哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin, mTOR)、磷酸化哺乳动物雷帕霉素靶蛋白(phosphorylated mTOR, p‑mTOR)表达量。 结果 与NC组比较,其余各组HR、±dp/dtmax、LVDP降低,LVEDP、心肌梗死面积、冠状动脉流出液LDH活性升高,心肌LC3‑Ⅱ表达上调,p‑Akt及p‑mTOR表达下调(P均<0.05)。与I/R组比较,Dex+I/R组心率、±dp/dtmax、LVDP增加,LVEDP、心肌梗死面积、冠状动脉流出液LDH活性降低,心肌LC3‑Ⅱ表达下调,p‑Akt及p‑mTOR表达上调(P均<0.05)。与Dex+I/R组比较,Dex+I/R+W组心率、±dp/dtmax、LVDP降低, LVEDP、心肌梗死面积、冠状动脉流出液LDH活性升高,心肌LC3‑Ⅱ表达上调,p‑Akt及p‑mTOR表达下调(P均<0.05)。 结论 Dex预处理对离体大鼠心脏缺血/再灌注损伤具有保护作用,且该作用可能与PI3K/Akt信号通路激活,引起下游mTOR活性增强从而降低缺血/再灌注期间心肌细胞的自噬水平有关。

关键词: 右美托咪定; 心肌; 缺血/再灌注损伤; 微管相关蛋白质; 自噬
Abstract:

Objective To observe the effects of dexmedetomidine (Dex) on microtubule‑associated protein 1 light 3 (LC3) and phosphatidy‑linositol 3‑kinase/protein kinase B (PI3K/Akt) signal pathway in isolated rat heart during ischemia‑reperfusion injury, and to explore the protective effects of Dex on myocardium. Methods A total of 48 healthy adult male SD rats (8−10 weeks old and weighing 250−300 g) were used to establish an isolated heart model of ischemia‑reperfusion with Langendorff perfusion device. After successful modeling, a 48 rat hearts were divided into 4 groups (n=12), according to the random number table method: a blank control group (group NC, which was continuously perfused with K‑H solution over 120 min), an ischemia‑reperfusion group (group I/R, which was perfused with K‑H solution over 30 min followed by global ischemia for 30 min, and reperfusion over 60 min), a Dex preconditioning group (group Dex+I/R, which was perfused with K‑H solution over 10 min followed by infusion of K‑H solution containing 25 μg/L Dex for 15 min, elution of K‑H solution for 5 min, ischemia for 30 min, and reperfusion for 60 min), a Dex preconditioning+Warman group (group Dex+I/R+W, which was intraperitoneally injected with 15 μg/kg of Warman 30 min before thoracotomy, along with the similar treatments with group Dex+I/R). Their heart rate (HR), left ventricular diastolic pressure (LVEDP), left ventricular developed pressure (LVDP), the maximum rate of increase or decrease of left ventricular pressure (±dp/dtmax) were recorded at the end of equilibrium (after infusion over 30 min) and reperfusion. The coronary perfusion fluid was collected at the end of reperfusion and the level of lactate dehydrogenase (LDH) was examined by a microplate reader. The myocardiac tissues were taken and myocardial infarct size was measured by 2, 3, 5‑triphenyltetrazolium chloride (TTC) staining, and the percentage of myocardial infarct size was calculated. The expression of autophagosomal marker LC3, Akt, phosphorylated Akt (p‑Akt), mammalian target of rapamycin (mTOR), and phosphorylated mTOR (p‑mTOR) was determined by Western blot. Results Compared with group NC, remarkable decreases in HR, ±dp/dtmax, and LVDP and the levels of p‑Akt and p‑mTOR as well as increases in LVEDP, myocardial infarction size, and the activity of LDH in coronary perfusion fluid, and the level of myocardial LC3 were found in other groups (P<0.05). Compared with group I/R, remarkable increases in HR, ±dp/dtmax, and LVDP and the levels of p‑Akt and p‑mTOR as well as decreases in LVEDP, myocardial infarction size, and the activity of LDH in coronary perfusion fluid, and the level of myocardial LC3 were found in group Dex+I/R (P<0.05). Compared with group Dex+I/R, remarkable decreases in HR, ±dp/dtmax and LVDP and the levels of p‑Akt and p‑mTOR as well as increases in LVEDP, myocardial infarction size, and the activity of LDH in coronary perfusion fluid, and the level of myocardial LC3 were found in group Dex+I/R+W (P<0.05). Conclusions Dex preconditioning can protect ischemia‑reperfusion injury in isolated rat heart, which may be related to decreased autophagy in cardiomyocytes during ischemia reperfusion period through activating PI3K/Akt signal pathway and enhancing downstream mTOR.

Key words: Dexmedetomidine; Myocardium; Ischemia/reperfusion injury; Microtubule‑associated protein; Autophagy